Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,863.12 +1,468.42 (+2.25%) CMC Crypto 200
1,350.62 -23.22 (-1.67%)
Corbion N.V. (CSU.F)
| Previous close | 21.00 |
| Open | 20.40 |
| Bid | 20.00 x N/A |
| Ask | 21.80 x N/A |
| Day's range | 20.40 - 20.40 |
| 52-week range | 15.00 - 28.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 1.241B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | 16.72 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.61 (2.90%) |
| Ex-dividend date | 17 May 2024 |
| 1y target est | N/A |
- GlobeNewswire
Corbion reports the progress of its € 20 million share buyback program 6 May – 10 May 2024
Corbion hereby reports the transaction details related to its € 20 million share buyback program announced on 26 April 2024. During the week of 6 May up to and including 10 May 2024 a total of 56,299 shares were repurchased at an average price of €21.3620 for a total amount of €1,202,658.73. To date, the total consideration for shares repurchased amounts to €1,999,484.52 representing 10.00% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of the
- GlobeNewswire
Corbion reports the progress of its € 20 million share buyback program 29 April – 3 May 2024
Corbion hereby reports the transaction details related to its € 20 million share buyback program announced on 26 April 2024. During the week of 29 April up to and including 3 May 2024 a total of 38,702 shares were repurchased at an average price of €20.5887 for a total amount of €796,825.79. To date, the total consideration for shares repurchased amounts to €796,825.79 representing 3.98% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of the pr
- GlobeNewswire
Corbion: Q1 2024 Interim Management Statement
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for the quarter ending 31 March 2024. Key highlights first quarter of 2024 Organic growth core activities: Sales: volume/mix +1.7%, price -4.5%Adjusted EBITDA: +0.7%Adjusted EBITDA margin 13.8% (+ 50bps versus last year) Sales € 344.3 million; an organic decrease of -3.4%Adjusted EBITDA € 47.2 million; an organic decrease of -1.2%Positive Free
